Waldman Lawrence 4
4 · Apyx Medical Corp · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Apyx Medical Director Lawrence Waldman Exercises Options
What Happened
Lawrence Waldman, a director of Apyx Medical Corp (APYX), exercised 12,000 stock options on June 30, 2026 (transaction code M). The exercise price was $1.88 per share, for an aggregate exercise cost of $22,560. To cover the exercise cost (and/or tax obligations), 5,024 shares were withheld by the issuer at $4.49 per share (transaction code F), valued at about $22,558, resulting in 6,976 net shares issued to Waldman. The filing also records the extinguishment/disposition of the 12,000 derivative interests that were exercised.
Key Details
- Transaction date: June 30, 2026 (filed July 2, 2026). The filing appears to have been made within the usual two-business-day window.
- Option exercise: 12,000 options exercised at $1.88/share — total cost $22,560.
- Withholding: 5,024 shares withheld at $4.49/share (≈ $22,558) to satisfy exercise price/tax obligations; 6,976 net shares issued.
- Shares owned after transaction: the filing supplies the 6,976 net shares issued; total beneficial ownership after the transaction is not specified in the information provided here.
- Footnotes: (F1) Some securities are held by a Spousal Lifetime Access Trust (SLAT); the reporting person disclaims beneficial ownership of SLAT-held securities. (F2) Confirms the net exercise/cashless-withholding arrangement described above.
- Transaction codes: M = option exercise/conversion; F = payment of exercise price/tax liability via share withholding.
Context
This was an option exercise with share withholding (a common “net exercise” or cashless-style settlement) rather than an open-market sale. The withheld shares were used to cover the exercise price (and possibly related tax withholding) and do not necessarily signal a decision to sell shares on the market. The derivative disposition at $0 reflects the options being converted/settled upon exercise.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-30$1.88/sh+12,000$22,560→ 17,338 total(indirect: By SLAT) - Tax Payment
Common Stock
[F1]2026-06-30$4.49/sh−5,024$22,558→ 12,314 total(indirect: By SLAT) - Exercise/Conversion
Stock option (right to buy)
[F2][F1]2026-06-30−12,000→ 0 total(indirect: By SLAT)Exercise: $1.88Exp: 2026-07-28→ Common Stock (12,000 underlying)
- 37,563
Common Stock
Footnotes (2)
- [F1]Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.
- [F2]On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person.